Pure Global
NCT06326242

What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials

Toward a Patient-centered Early Drug Development in Oncology: What Unmet Need for the Patients? A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
European Institute of Oncology·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Solid Tumor
Drug/Device/Intervention
Solid Tumor
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
European Institute of Oncology
Location
Milano, Italy
Timeline & enrollment
Phase
N/A
Start date
Mar 27, 2023
End date
Dec 31, 2024
Enrollment
100 participants
Primary outcome

The geographical accessibility of patients attending the Phase 1 facility of the European Institute of Oncology (IEO).

Summary

An observational prospective study of patients enrolled and treated with experimental drugs
 in Phase I studies.

ICD-10 classifications
Malignant neoplasm: Connective and soft tissue, unspecifiedCarcinoma in situ, unspecifiedMalignant neoplasm: ParametriumMalignant neoplasm of other connective and soft tissueMalignant neoplasm: Lip, unspecified, inner aspect
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06326242
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06326242 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruiting. The study focuses on Solid Tumor. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.